A thiazolidinedione for hepatitis B
Thiazolidinediones may hold the key to developing a new class of anti-HBV medicines that will cure the chronic infection.
Preparing for the 2024 ‘tripledemic’
Now is the time to arm Australians with vaccines, respiratory disease advice, testing and essential medicines to get ahead of respiratory ailment season.
The trifecta...
Oral Antihyperglycaemics for COPD exacerbations
Emerging evidence is pointing to the benefits of ‘novel’ antihyperglycaemics on lung function in COPD patients.
One size does not fit all
When it comes to person-centred care, bespoke tailoring to every patient’s healthcare needs is fundamental.
Waiting to inhale
Annoyed by her glass squeeze-bulb nebuliser, 13-year old asthmatic Susie Maison asked "Daddy why can't they put my asthma medicine in a spray can?"